Riskpilot← Back to searchSign inGet full accessSurgical Science Sweden AB
ABActiveOrg 5565448783Drakegatan 7 A 3 VånResearch and experimental development on natural sciences and engineering · NACE 7210Est. 199750 employees
Revenue 2024
SEK 126,6M
+21% vs 2023
EBITDA margin
-2.7%
-119% vs 2023
Equity ratio
90.4%
Financial strength
Net profit 2024
SEK 53,5M
-28% vs 2023
| Revenue | SEK 126,6M | +21% |
| EBITDA | SEK -3,5M | -119% |
| Net profit | SEK 53,5M | -28% |
| Total assets | SEK 3,9B | +9% |
| Equity | SEK 3,6B | +2% |
| Employees | 50 | — |
Legal name
Surgical Science Sweden AB
Org number
5565448783
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
1 augusti 1997
Share capital
SEK 2 551 000
Employees
50 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av ledamöterna i förening med Ahlberg, Anna Sofia Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska på kommersiella grunder bedriva utbildning i kirurgi, testa och utveckla nya kirurgiska produkter och metoder, utveckla och patentera nya idéer inom det medicinska området, bedriva forskning inom de områden, som kan gagna företagets verksamhet även idka därmed förenlig verksamhet.
Address
Drakegatan 7 A 3 Vån
Phone
+46317416560
Email
info@surgicalscience.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 49 449 | 89 626 | 87 015 | 104 777 | 126 574 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −5 268 | 21 532 | −17 714 | 18 023 | −3 457 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | −5 268 | 21 532 | −17 714 | 18 023 | −3 457 |
| Net financials | −15 193 | −40 245 | −2 961 | 22 375 | 1 965 |
| Profit before tax | −14 540 | 24 007 | 19 923 | 93 356 | 67 901 |
| Tax | −103 | 5 572 | −4 388 | −19 586 | −14 437 |
| Net profit | −14 643 | 29 579 | 15 535 | 73 770 | 53 464 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 425 651 | 3 544 110 | 3 532 282 | 3 622 559 | 3 946 300 |
| Equity | 408 222 | 3 391 988 | 3 409 532 | 3 506 675 | 3 567 761 |
| Long-term debt | 1 965 | 450 | 150 | 0 | 0 |
| Short-term debt | 15 464 | 28 436 | 41 024 | 115 884 | 378 539 |
| Total debt | 17 429 | 28 886 | 41 174 | 115 884 | 378 539 |
EBITDA margin
-2.7%
This company
15.8%
Market median
-117% vs market
20202024
Equity ratio
90.4%
This company
38.2%
Market median
+137% vs market
20202024
Return on equity
1.5%
This company
18.4%
Market median
-92% vs market
20202024
Net profit margin
42.2%
This company
8.1%
Market median
+421% vs market
20202024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20202024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
AS External Signatory | External Signatory | 2022 |
JD Chief Auditor | Chief Auditor | 2020 |
TE Chief Executive Officer | Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (7) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Board of Directors | 2022 | |
| Chairman | 2025 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Surgical Science Sweden AB (this company)
Mimic Technologies IncMimic Technologies, Inc.Simbionix, CorpSURGICAL SCIENCE NORTH AMERICASurgical Science North AmericaMIMIC TECHNOLOGIES, INC.Surgical Science IncBoard members of Surgical Science Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Sofia Ahlberg | External Signatory | 0 companies |
| Johan Daniel Haglund | Chief Auditor | 0 companies |
| Tom Erik Ilmar Englund | Chief Executive Officer | 0 companies |
| Elisabeth Ann Kristina Hansson | Board of Directors | 0 companies |
| Jan Olof Roland Bengtsson | Board of Directors | 0 companies |
| Åsa Maria Kristina Bredin | Board of Directors | 0 companies |
| Nils Henrik Falconer | Board of Directors | 0 companies |
| Thomas Lennart Eklund | Board of Directors | 0 companies |
| Gisli Hennermark | Chairman | 0 companies |
| Jan Bertil Bengtsson | Board of Directors | 0 companies |
| Nils Gunnar Sellbom | Board of Directors | 0 companies |